Le Lézard
Classified in: Health
Subject: RCL

Food Recall Warning (Allergen) - Cappola brand Genoa Salami recalled due to undeclared milk and wheat


Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/cappola-brand-genoa-salami-recalled-due-undeclared-milk-and-wheat

OTTAWA, ON, Nov. 4, 2022 /CNW/ - 

Summary

Affected products

Brand

Product

Size

UPC

Codes

Cappola

Genoa Salami

175 g

0 63100 15111 9

Best Before 23JA03, 23JA04, and
23JA09

 

Issue

The affected product is being recalled from the marketplace because it contains milk and wheat which are not declared on the label.

The recalled product has been sold nationally.

What you should do

Learn more:

Background

This recall was triggered by the company.

There have been no reported reactions associated with the consumption of this product.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...

at 07:00
XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that further to its press releases of March 11 and April 30,...

at 06:18
With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories...

at 05:50
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:35
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...

at 05:02
'Companion Diagnostics: Technologies and Markets' is all about using special tests alongside certain medicines to figure out which treatment will work best for each person. These tests are called companion diagnostics because they go together with...



News published on and distributed by: